Alto Neuroscience to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Alto Neuroscience (NYSE: ANRO), a clinical-stage biopharmaceutical company developing precision medicines for neuropsychiatric disorders, has announced its participation in two major investor conferences in November 2024. The company will present at the Stifel 2024 Healthcare Conference in New York on November 18 at 3:00 pm ET, and the Jefferies London Healthcare Conference on November 20 at 3:00 pm GMT. Both events will feature fireside chats and one-on-one investor meetings. Presentations will be available via webcast on Alto's website with replay options available.

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company management team will present at the following upcoming investor conferences and events in November:

• Stifel 2024 Healthcare Conference, November 18-19^th 2024:
  • Format: Fireside chat and one-on-one investor meetings
  • Presentation Date/Time: Monday, November 18, 2024, at 3:00 pm ET
  • Location: Lotte New York Palace, New York
• Jefferies London Healthcare Conference, November 19-21^st 2024:
  • Format: Fireside chat and one-on-one investor meetings
  • Presentation Date/Time: Wednesday, November 20, 2024, at 3:00 pm Greenwich Time (GMT)
  • Location: The Waldorf Hilton, London, United Kingdom

Available presentations will be accessible via live webcast on the Events and Presentations page in the Investors section of Alto’s website and a replay will be available following the presentation.

About Alto Neuroscience

Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Alto’s Precision Psychiatry Platform™ measures brain biomarkers by analyzing EEG activity, neurocognitive assessments, wearable data, and other factors to better identify which patients are more likely to respond to Alto product candidates. Alto’s clinical-stage pipeline includes novel drug candidates in depression, PTSD, schizophrenia, and other mental health conditions.

For more information, visit www.altoneuroscience.com or follow Alto on X (Twitter).

Availability of Information on Alto’s Website

Alto routinely uses its investor relations website to post presentations to investors and other important information, including information that may be material. Accordingly, Alto encourages investors and others interested in Alto to review the information it makes public on its investor relations website.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241104598748/en/

Investor Contact:

Nick Smith

investors@altoneuroscience.com

Media Contact:

Mari Purpura

media@altoneuroscience.com

Source: Alto Neuroscience, Inc.

FAQ

When is Alto Neuroscience (ANRO) presenting at the Stifel Healthcare Conference 2024?

Alto Neuroscience will present at the Stifel Healthcare Conference on Monday, November 18, 2024, at 3:00 pm ET at the Lotte New York Palace.

Where can I watch Alto Neuroscience's (ANRO) investor conference presentations?

The presentations will be accessible via live webcast on the Events and Presentations page in the Investors section of Alto's website, with replays available afterward.

What type of presentations will Alto Neuroscience (ANRO) give at the November 2024 conferences?

Alto Neuroscience will participate in fireside chats and conduct one-on-one investor meetings at both the Stifel and Jefferies conferences.

When is Alto Neuroscience's (ANRO) presentation at the Jefferies London Healthcare Conference?

Alto Neuroscience will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024, at 3:00 pm Greenwich Time (GMT) at The Waldorf Hilton, London.